1. Calcium dobesilate (2,5-dihydroxybenzene sulfonate) is a drug commo
nly used in the treatment of diabetic retinopathy and chronic venous i
nsufficiency. 2. The pharmacology of calcium dobesilate reveals its ab
ility to decrease capillary permeability, as well as platelet aggregat
ion and blood viscosity. 3. Furthermore, recent data show that calcium
dobesilate increases endothelium dependent relaxation owing to an inc
rease in nitric oxide synthesis. GEN PHARMAC 31;3:357-360, 1998. (C) 1
998 Elsevier Science Inc.